T. Rowe Price Associates’s eHealth EHTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $95K | Buy |
73,336
+15,600
| +27% | +$36.2K | ﹤0.01% | 3011 |
|
|
2025
Q4 | $266K | Buy |
57,736
+14,800
| +34% | +$65.2K | ﹤0.01% | 2702 |
|
|
2025
Q3 | $186K | Hold |
42,936
| – | – | ﹤0.01% | 2812 |
|
|
2025
Q2 | $187K | Buy |
42,936
+14,036
| +49% | +$70.4K | ﹤0.01% | 2737 |
|
|
2025
Q1 | $194K | Buy |
28,900
+9,500
| +49% | +$86.4K | ﹤0.01% | 2655 |
|
|
2024
Q4 | $183K | Hold |
19,400
| – | – | ﹤0.01% | 2717 |
|
|
2024
Q3 | $80K | Sell |
19,400
-2,323
| -11% | -$10K | ﹤0.01% | 2862 |
|
|
2024
Q2 | $99K | Sell |
21,723
-7,571
| -26% | -$38.1K | ﹤0.01% | 2761 |
|
|
2024
Q1 | $177K | Buy |
29,294
+817
| +3% | +$5.42K | ﹤0.01% | 2655 |
|
|
2023
Q4 | $249K | Buy |
28,477
+269
| +1% | +$2.2K | ﹤0.01% | 2452 |
|
|
2023
Q3 | $209K | Buy |
28,208
+1,381
| +5% | +$10.8K | ﹤0.01% | 2488 |
|
|
2023
Q2 | $216K | Sell |
26,827
-2,800
| -9% | -$22.4K | ﹤0.01% | 2498 |
|
|
2023
Q1 | $278K | Buy |
29,627
+4,047
| +16% | +$31.8K | ﹤0.01% | 2385 |
|
|
2022
Q4 | $124K | Buy |
25,580
+676
| +3% | +$2.52K | ﹤0.01% | 2671 |
|
|
2022
Q3 | $98K | Buy |
24,904
+4,569
| +22% | +$31.9K | ﹤0.01% | 2733 |
|
|
2022
Q2 | $190K | Sell |
20,335
-4,491
| -18% | -$45.7K | ﹤0.01% | 2616 |
|
|
2022
Q1 | $308K | Sell |
24,826
-146,389
| -86% | -$2.52M | ﹤0.01% | 2539 |
|
|
2021
Q4 | $4.37M | Sell |
171,215
-28,125
| -14% | -$934K | ﹤0.01% | 1511 |
|
|
2021
Q3 | $8.07M | Sell |
199,340
-34,050
| -15% | -$1.59M | ﹤0.01% | 1448 |
|
|
2021
Q2 | $13.6M | Buy |
233,390
+16,281
| +7% | +$1.07M | ﹤0.01% | 1373 |
|
|
2021
Q1 | $15.8M | Sell |
217,109
-139,320
| -39% | -$8.91M | ﹤0.01% | 1328 |
|
|
2020
Q4 | $25.2M | Buy |
356,429
+69,392
| +24% | +$5.27M | ﹤0.01% | 1163 |
|
|
2020
Q3 | $22.7M | Buy |
287,037
+273,620
| +2,039% | +$22.2M | ﹤0.01% | 1118 |
|
|
2020
Q2 | $1.32M | Buy |
13,417
+724
| +6% | +$84.2K | ﹤0.01% | 1672 |
|
|
2020
Q1 | $1.79M | Sell |
12,693
-58,331
| -82% | -$6.69M | ﹤0.01% | 1529 |
|
|
2019
Q4 | $6.82M | Sell |
71,024
-39,148
| -36% | -$3.04M | ﹤0.01% | 1360 |
|
|
2019
Q3 | $7.36M | Buy |
110,172
+683
| +0.6% | +$61.6K | ﹤0.01% | 1330 |
|
|
2019
Q2 | $9.43M | Buy |
109,489
+34,652
| +46% | +$2.33M | ﹤0.01% | 1321 |
|
|
2019
Q1 | $4.67M | Buy |
74,837
+65,884
| +736% | +$3.63M | ﹤0.01% | 1412 |
|
|
2018
Q4 | $344K | Buy |
8,953
+50
| +0.6% | +$1.68K | ﹤0.01% | 2232 |
|
|
2018
Q3 | $252K | Buy |
+8,903
| New | +$236K | ﹤0.01% | 2407 |
|
|
2017
Q4 | – | Sell |
-8,844
| Closed | -$211K | – | 2575 |
|
|
2017
Q3 | $211K | Buy |
+8,844
| New | +$180K | ﹤0.01% | 2395 |
|
|
2015
Q1 | – | Sell |
-8,800
| Closed | -$219K | – | 2549 |
|
|
2014
Q4 | $219K | Hold |
8,800
| – | – | ﹤0.01% | 2318 |
|
|
2014
Q3 | $212K | Hold |
8,800
| – | – | ﹤0.01% | 2310 |
|
|
2014
Q2 | $334K | Hold |
8,800
| – | – | ﹤0.01% | 2129 |
|
|
2014
Q1 | $447K | Sell |
8,800
-1,042,100
| -99% | -$54.3M | ﹤0.01% | 1964 |
|
|
2013
Q4 | $48.9M | Sell |
1,050,900
-4,500
| -0.4% | -$188K | 0.01% | 845 |
|
|
2013
Q3 | $34M | Sell |
1,055,400
-56,900
| -5% | -$1.57M | 0.01% | 944 |
|
|
2013
Q2 | $25.3M | Buy |
+1,112,300
| New | +$25M | 0.01% | 1006 |
|
Other funds holding EHTH
NCM
PAI
VCM
RCM
T. Rowe Price Associates's EHTH Position: Q1 2026 in Review
T. Rowe Price Associates increased its eHealth (EHTH) stake by 27% in Q1 2026, buying an estimated $36.2K and bringing the position to 73,336 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #3011.
T. Rowe Price Associates first reported a position in EHTH in Q2 2013 and has held it in 39 quarters since. The position peaked at $48.9M in Q4 2013. 104 funds tracked by Wall St. Rank hold EHTH as of Q1 2026.
- T. Rowe Price Associates held 73,336 shares of eHealth worth $95K as of Q1 2026.
- T. Rowe Price Associates bought 15,600 eHealth shares in Q1 2026, an estimated $36.2K.
- eHealth made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3011 holding.
- T. Rowe Price Associates first reported a position in eHealth in Q2 2013 and has held it in 39 quarters since.
- T. Rowe Price Associates's eHealth position peaked at $48.9M in Q4 2013.
- 104 funds tracked by Wall St. Rank held eHealth as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.